LeMaitre Vascular, Inc. LHU.F Stock
LeMaitre Vascular, Inc. Price Chart
LeMaitre Vascular, Inc. LHU.F Financial and Trading Overview
LeMaitre Vascular, Inc. stock price | 61 EUR |
Previous Close | 61.5 EUR |
Open | 60.5 EUR |
Bid | 60.5 EUR x 0 |
Ask | 62.5 EUR x 0 |
Day's Range | 60.5 - 60.5 EUR |
52 Week Range | 39.2 - 61 EUR |
Volume | 2 EUR |
Avg. Volume | 0 EUR |
Market Cap | 1.38B EUR |
Beta (5Y Monthly) | 0.977112 |
PE Ratio (TTM) | 69.54023 |
EPS (TTM) | 1.25 EUR |
Forward Dividend & Yield | 0.52 (0.85%) |
Ex-Dividend Date | May 16, 2023 |
1y Target Est | 66.14 EUR |
LHU.F Valuation Measures
Enterprise Value | 1.29B EUR |
Trailing P/E | 69.54023 |
Forward P/E | 41.438354 |
PEG Ratio (5 yr expected) | -24.21 |
Price/Sales (ttm) | 8.143011 |
Price/Book (mrq) | 4.886125 |
Enterprise Value/Revenue | 7.608 |
Enterprise Value/EBITDA | 32.503 |
Trading Information
LeMaitre Vascular, Inc. Stock Price History
Beta (5Y Monthly) | 0.977112 |
52-Week Change | 54.82% |
S&P500 52-Week Change | 20.43% |
52 Week High | 61 EUR |
52 Week Low | 39.2 EUR |
50-Day Moving Average | 52.96 EUR |
200-Day Moving Average | 47.46 EUR |
LHU.F Share Statistics
Avg. Volume (3 month) | 0 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 22.16M |
Float | 19.74M |
Short Ratio | N/A |
% Held by Insiders | 11.79% |
% Held by Institutions | 87.66% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.515 |
Trailing Annual Dividend Yield | 0.83% |
5 Year Average Dividend Yield | 98.00% |
Payout Ratio | 0.5538 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 12.19% |
Operating Margin (ttm) | 17.84% |
Gross Margin | 64.91% |
EBITDA Margin | 23.40% |
Management Effectiveness
Return on Assets (ttm) | 6.21% |
Return on Equity (ttm) | 7.75% |
Income Statement
Revenue (ttm) | 169.16M EUR |
Revenue Per Share (ttm) | 7.68 EUR |
Quarterly Revenue Growth (yoy) | 19.00% |
Gross Profit (ttm) | 104.9M EUR |
EBITDA | 39.6M EUR |
Net Income Avi to Common (ttm) | 20.64M EUR |
Diluted EPS (ttm) | 0.87 |
Quarterly Earnings Growth (yoy) | 0% |
Balance Sheet
Total Cash (mrq) | 81.01M EUR |
Total Cash Per Share (mrq) | 3.66 EUR |
Total Debt (mrq) | 16.51M EUR |
Total Debt/Equity (mrq) | 6.02 EUR |
Current Ratio (mrq) | 6.893 |
Book Value Per Share (mrq) | 12.382 |
Cash Flow Statement
Operating Cash Flow (ttm) | 22.95M EUR |
Levered Free Cash Flow (ttm) | 19.97M EUR |
Profile of LeMaitre Vascular, Inc.
Country | Germany |
State | MA |
City | Burlington |
Address | 63 Second Avenue |
ZIP | 01803 |
Phone | 781 221 2266 |
Website | https://www.lemaitre.com |
Industry | Medical Instruments & Supplies |
Sector(s) | Healthcare |
Full Time Employees | 591 |
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers restoreflow allografts; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access in patients with or without a previously-failed synthetic graft; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular and cardiac patches, which are used for closure of vessels after surgical intervention; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.
Q&A For LeMaitre Vascular, Inc. Stock
What is a current LHU.F stock price?
LeMaitre Vascular, Inc. LHU.F stock price today per share is 61 EUR.
How to purchase LeMaitre Vascular, Inc. stock?
You can buy LHU.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for LeMaitre Vascular, Inc.?
The stock symbol or ticker of LeMaitre Vascular, Inc. is LHU.F.
Which industry does the LeMaitre Vascular, Inc. company belong to?
The LeMaitre Vascular, Inc. industry is Medical Instruments & Supplies.
How many shares does LeMaitre Vascular, Inc. have in circulation?
The max supply of LeMaitre Vascular, Inc. shares is 22.34M.
What is LeMaitre Vascular, Inc. Price to Earnings Ratio (PE Ratio)?
LeMaitre Vascular, Inc. PE Ratio is 48.80000000 now.
What was LeMaitre Vascular, Inc. earnings per share over the trailing 12 months (TTM)?
LeMaitre Vascular, Inc. EPS is 1.25 EUR over the trailing 12 months.
Which sector does the LeMaitre Vascular, Inc. company belong to?
The LeMaitre Vascular, Inc. sector is Healthcare.